Skip to content

Harrow HROW Asset turnover

Asset turnover at other companies

AbbVie logo
AbbVieABBV
0.5×+0.1×
Bausch + Lomb logo
Bausch + LombBLCO
0.4×0.0×
Ocular Therapeutix logo
Ocular TherapeutixOCUL
0.1×0.0×
Viatris logo
ViatrisVTRS
0.4×+0.1×
Bausch Health Companies logo
Bausch Health CompaniesBHC
0.4×0.0×
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
+0.4×

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Calculated from Harrow’s reported figures.

Based on trailing twelve months.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's asset turnover.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's asset turnover?
Harrow (HROW) reported asset turnover of 0.7× in Q1 2026.
How has Harrow's asset turnover changed year-over-year?
Harrow's asset turnover increased by 6.3% year-over-year, from 0.6× to 0.7×.
What is the long-term trend for Harrow's asset turnover?
Over 5 years (2020 to 2025), Harrow's asset turnover has grown at a -3.8% compound annual growth rate (CAGR), from 0.8× to 0.7×.
What does asset turnover mean?
Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.